New At-Home calming treatment tested for mental health crises

NCT ID NCT05658510

Summary

This study tested a medication called BXCL501 to see if it could safely and effectively calm episodes of agitation when used at home by adults with schizophrenia or bipolar disorder. In the second part of the trial, 452 participants used the medication as needed over 12 weeks at home, while being monitored for safety. The goal was to provide a fast-acting option to manage severe agitation outside of a clinic or hospital setting.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • BioXcel Clinical Research Site 102

    DeSoto, Texas, 75115, United States

  • BioXcel Clinical Research Site 103

    Gaithersburg, Maryland, 20877, United States

  • BioXcel Clinical Research Site 104

    Orange, California, 92868, United States

  • BioXcel Clinical Research Site 105

    Berlin, New Jersey, 08009, United States

  • BioXcel Clinical Research Site 108

    Garden Grove, California, 92845, United States

  • BioXcel Clinical Research Site 110

    Culver City, California, 90230, United States

  • BioXcel Clinical Research Site 113

    Bellflower, California, 90706, United States

  • BioXcel Clinical Research Site 114

    Riverside, California, 92506, United States

  • BioXcel Clinical Research Site 117

    Lemon Grove, California, 91945, United States

  • BioXcel Clinical Research Site 118

    Las Vegas, Nevada, 89102, United States

  • BioXcel Clinical Research Site 121

    Los Angeles, California, 90015, United States

  • BioXcel Clinical Research Site 122

    Beachwood, Ohio, 44122, United States

  • BioXcel Clinical Research Site 123

    Oceanside, California, 92056, United States

  • BioXcel Clinical Research Site 124

    Miami, Florida, 33186, United States

  • BioXcel Clinical Research Site 125

    Irving, Texas, 75062, United States

  • BioXcel Clinical Research Site 126

    Everett, Washington, 98201, United States

  • BioXcel Clinical Research Site 127

    Plano, Texas, 75093, United States

  • BioXcel Clinical Research Site 128

    Cerritos, California, 90703, United States

  • BioXcel Clinical Research Site 129

    Denver, Colorado, 80209, United States

  • BioXcel Clinical Research Site 130

    Elgin, Illinois, 60123, United States

  • BioXcel Clinical Research Site 131

    Miami, Florida, 33122, United States

  • BioXcel Clinical Research Site 133

    Rancho Cucamonga, California, 91730, United States

  • BioXcel Clinical Research Site 136

    Austin, Texas, 78754, United States

  • BioXcel Clinical Research Site 137

    Las Vegas, Nevada, 89119, United States

Conditions

Explore the condition pages connected to this study.